Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 181.5% in February
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 181.5% in February
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) was the recipient of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 86,700 shares, a growth of 181.5% from the February 13th total of 30,800 shares. Based on an average daily volume of 219,900 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.4% of the company's shares are sold short.
Entera Bio Ltd.（纳斯达克股票代码：ENTX — Get Rating）是2月份空头利率大幅增长的受益者。截至2月28日，空头利率共计86,700股，较2月13日的30,800股增长了181.5％。根据219,900股的平均每日成交量，目前天数与覆盖率为0.4天。目前，该公司0.4％的股票被卖空。
Entera Bio Stock Down 5.0 %
Entera Bio 股票下跌 5.0 ％
Shares of ENTX traded down $0.06 during trading hours on Friday, reaching $1.15. 180,251 shares of the company traded hands, compared to its average volume of 288,118. Entera Bio has a 12-month low of $0.47 and a 12-month high of $3.00. The stock's fifty day moving average price is $0.95 and its 200 day moving average price is $0.93.
周五交易时段，ENTX的股价下跌了0.06美元，至1.15美元。该公司的股票交易量为180,251股，而平均交易量为288,118股。Entera Bio创下12个月低点0.47美元，12个月高点为3.00美元。该股的五十天移动平均价格为0.95美元，其200天移动平均线价格为0.93美元。
Institutional Trading of Entera Bio
Entera Bio 的机构交易
A number of large investors have recently made changes to their positions in the stock. Renaissance Technologies LLC raised its holdings in shares of Entera Bio by 555.4% in the fourth quarter. Renaissance Technologies LLC now owns 139,600 shares of the company's stock valued at $102,000 after acquiring an additional 118,300 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Entera Bio by 358.5% in the fourth quarter. Millennium Management LLC now owns 46,000 shares of the company's stock valued at $34,000 after acquiring an additional 35,968 shares in the last quarter. Finally, PNC Financial Services Group Inc. bought a new stake in shares of Entera Bio in the first quarter valued at about $29,000. 20.12% of the stock is owned by hedge funds and other institutional investors.
许多大型投资者最近改变了他们在股票中的头寸。Renaissance Technologies LLC在第四季度将其持有的Entera Bio股票增加了555.4％。Renaissance Technologies LLC在上个季度又收购了118,300股股票后，现在拥有该公司139,600股股票，价值10.2万美元。Millennium Management LLC在第四季度将其持有的Entera Bio股票增加了358.5％。Millennium Management LLC在上个季度又收购了35,968股股票后，现在拥有该公司46,000股股票，价值34,000美元。最后，PNC Financial Services Group Inc.在第一季度购买了Entera Bio的新股份，价值约29,000美元。该股中有20.12％由对冲基金和其他机构投资者持有。
About Entera Bio
关于 Entera Bio
(Get Rating)
（获取评分）
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Entera Bio Ltd. 是一家临床阶段的生物制药公司，从事口服大分子疗法的开发和商业化。它的产品线包括PTH、GLP-E和HGH，该公司成立于2009年9月30日，总部位于以色列耶路撒冷。
Featured Stories
精选故事
- Get a free copy of the StockNews.com research report on Entera Bio (ENTX)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
- 免费获取 StockNews.com 关于 Entera Bio (ENTX) 的研究报告的副本
- 2 只海上钻探股票将获得丰厚利润
- 三只主打股有两位数的上涨空间
- 投资者能否信任消费者提升美国户外品牌？
- 如何购买高收益股息股票
- 甲骨文发表讲话：股价下跌5％
Receive News & Ratings for Entera Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entera Bio and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Entera Bio Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Entera Bio及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。